awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38923977-15CB766D-598C-4EBC-8574-19AA8375B713
Q38923977-15CB766D-598C-4EBC-8574-19AA8375B713
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38923977-15CB766D-598C-4EBC-8574-19AA8375B713
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
P2860
Q38923977-15CB766D-598C-4EBC-8574-19AA8375B713
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38923977-15CB766D-598C-4EBC-8574-19AA8375B713
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6f6f058b35c475cc948682f6f1a4c24f088c392
P2860
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.